EQL

EQL Pharma is a Swedish pharmaceutical company that specializes in the development and commercialization of niche generic drugs. The company focuses on identifying off-patent medicines with limited competition, complex regulatory requirements, or specific manufacturing challenges to ensure a sustainable market position. Headquartered in Lund, EQL Pharma operates primarily in the Nordic region but is expanding its footprint across Europe through strategic partnerships. Their portfolio covers a wide range of therapeutic areas, including psychiatry, cardiology, and dermatology. By maintaining a lean organizational structure and outsourcing manufacturing, the company efficiently brings cost-effective treatment options to healthcare systems. EQL Pharma is publicly traded on the Nasdaq Stockholm exchange.